Stemirna Therapeutics
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors (NCT05949775) | Stemirna Therapeutics | 2023-07-20 |
| A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2 (NCT05911087) | Stemirna Therapeutics | 2023-06-20 |
| mRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs (NCT05686161) | Stemirna Therapeutics | 2022-10-19 |
| New Generation mRNA Booster Vaccine Against Emerging VOCs (NCT05580159) | Stemirna Therapeutics | 2022-10-01 |
| A Study of Neoantigen mRNA Personalised Cancer in Patients With Advanced Solid Tumors (NCT05198752) | Stemirna Therapeutics | 2022-03-18 |
| A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above (NCT05144139) | Stemirna Therapeutics | 2021-12-03 |
| Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer (NCT03908671) | Stemirna Therapeutics | 2019-10-18 |
Track Stemirna Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.